Cargando…

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands

INTRODUCTION: The rapid roll-out of novel COVID-19 vaccines made near real-time post-marketing safety surveillance essential to identify rare and long-term adverse events following immunization (AEFIs). In light of the ongoing booster vaccination campaigns, it is key to monitor changes in observed s...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Boor, Saskia C., Schmitz-de Vries, Else T.J., Smits, Dennis, Scholl, Joep H.G., Rolfes, Leàn, van Hunsel, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208249/ https://www.ncbi.nlm.nih.gov/pubmed/37286408 http://dx.doi.org/10.1016/j.vaccine.2023.05.053

Ejemplares similares

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
por: Scholl, Joep H.G., et al.
Publicado: (2017)

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
por: Rolfes, Leàn, et al.
Publicado: (2016)

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)

Time to onset in statistical signal detection revisited: A follow‐up study in long‐term onset adverse drug reactions
por: Scholl, Joep H.G., et al.
Publicado: (2019)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes
por: Rolfes, Leàn, et al.
Publicado: (2022)

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
por: Rolfes, Leàn, et al.
Publicado: (2017)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb
por: Vrolijk, Misha F., et al.
Publicado: (2020)

Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience
por: Oosterhuis, Ingrid, et al.
Publicado: (2022)

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Adverse drug reactions of montelukast in children and adults
por: Haarman, Meindina G., et al.
Publicado: (2017)

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database
por: Rolfes, Leàn, et al.
Publicado: (2018)

Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports
por: Klein, Kevin, et al.
Publicado: (2015)

Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Kant, Agnes, et al.
Publicado: (2022)

Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands
por: Kant, Agnes, et al.
Publicado: (2022)

Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
por: DAVIDSON, Linda, et al.
Publicado: (2022)

Basic design criteria for an SPS booster
por: Billinge, R
Publicado: (1976)

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
por: Smeets, Tim, et al.
Publicado: (2016)

Curling of Hair in Two Female Patients Taking Alitretinoin
por: Alting, Kim, et al.
Publicado: (2018)

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
por: Ekhart, Corine, et al.
Publicado: (2022)

Clustering of homicide with other adverse health outcomes in the Netherlands
por: van Breen, J.A., et al.
Publicado: (2022)

Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature
por: Duijster, Janneke W., et al.
Publicado: (2023)

Decrease in incidence of oral anticoagulant-related intracerebral hemorrhage over the past decade in the Netherlands
por: Peeters, Michaël TJ, et al.
Publicado: (2022)

Local availability of green and blue space and prevalence of common mental disorders in the Netherlands
por: de Vries, Sjerp, et al.
Publicado: (2016)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Unbearable Pruritus After Withdrawal of (Levo)cetirizine
por: Ekhart, Corine, et al.
Publicado: (2016)

Current training on the basics of robotic surgery in the Netherlands: Time for a multidisciplinary approach?
por: Brinkman, Willem, et al.
Publicado: (2016)

Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product
por: van Hunsel, Florence, et al.
Publicado: (2015)

COVID-19 outbreaks among crew on commercial ships at the Port of Rotterdam, the Netherlands, 2020 to 2021
por: Gebuis, Edward, et al.
Publicado: (2023)

New Viruses in Idiopathic Human Diarrhea Cases, the Netherlands
por: Smits, Saskia L., et al.
Publicado: (2014)

SI Parameter meeting N°3: Some basic parameters of the Booster
por: Brianti, G
Publicado: (1972)

Enteric Coronavirus in Ferrets, the Netherlands
por: Provacia, Lisette B.V., et al.
Publicado: (2011)

Novel Hepatitis E Virus in Ferrets, the Netherlands
por: Raj, V. Stalin, et al.
Publicado: (2012)

Common Adverse Events from Mixing COVID-19 Vaccine Booster in Hanoi, Vietnam
por: Hung, Pham Van, et al.
Publicado: (2023)

Cardiovascular prevention model from Kenyan slums to migrants in the Netherlands
por: van de Vijver, Steven, et al.
Publicado: (2015)

Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme
por: Kanizsai, Andrea, et al.
Publicado: (2023)

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom
por: Versteegen, Pauline, et al.
Publicado: (2021)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8elenno3mr15h0ptmrmetg5qka